S.I. No. 355/2010 - European Communities (Food Supplements) (Amendment) Regulations 2010.
Notice of the making of this Statutory Instrument was published in | ||
“Iris Oifigiúil” of 20th July, 2010. | ||
I, MARY HARNEY, Minister for Health and Children, in exercise of the powers conferred on me by section 3 of the European Communities Act 1972 (No. 27 of 1972), and for the purpose of giving further effect to Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 1 on the approximation of the laws of the Member States relating to food supplements, and for the purpose of giving partial effect to Commission Regulation (EC) No. 1170/2009 of 30 November 2009 2 amending Directive 2002/46/EC of the European Parliament and of the Council and Regulation (EC) No. 1925/2006 of the European Parliament and of the Council as regards the lists of vitamin and minerals and their forms that can be added to foods, including food supplements, hereby make the following regulations: | ||
1. (1) These Regulations may be cited as the European Communities (Food Supplements) (Amendment) Regulations 2010. | ||
(2) The Principal Regulations and these Regulations may be cited together as the European Communities (Food Supplements) Regulations 2007 and 2010 and shall be construed together as one. | ||
2. In these Regulations, “Principal Regulations” means European Communities (Food Supplements) Regulations 2007 ( S.I. No. 506 of 2007 ). | ||
3. The Principal Regulations are amended— | ||
(a) in Regulation 2(1), by substituting for the definition of “Directive” the following— | ||
“Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 1 on the approximation of the laws of the Member States relating to food supplements, as amended by Commission Directive 2006/37/EC of 30 March 2006 2 and Commission Regulation (EC) No. 1170/2009 of 30 November 2009 2A ” | ||
And by the addition of the following footnote to the definition of “Directive”— | ||
“ 2A OJ L 314, 1.12.2009, p. 36” | ||
| ||
(b) in Regulation 19, by substituting for paragraph (2) the following— | ||
“A person who is guilty of an offence under these Regulations is liable: | ||
(a) on summary conviction to a fine not exceeding €5,000 or at the discretion of the Court to imprisonment for a term not exceeding 6 months or both, or | ||
(b) on conviction on indictment, to a fine not exceeding €500,000, or imprisonment for a term not exceeding 3 years, or both.” | ||
(c) in Regulation 19 by inserting after paragraph (2) the following— | ||
“(3) Where a person is convicted of an offence under these Regulations, the court shall, unless it is satisfied that there are special and substantial reasons for not so doing, order the person to pay to the Authority or the official agency, as the case may be, the costs and expenses, measured by the court, incurred by the Authority or official agency in relation to the investigation, detection and prosecution of the offence, including costs and expenses incurred in the taking of samples, the carrying out of tests, examinations and analyses and in respect of the remuneration and other expenses of employees, consultants and advisors engaged by the Authority or official agency. | ||
(4) An order for costs and expenses under subsection (3) is in addition to, and not instead of, any fine or penalty the court may impose under subsection (2).” | ||
(d) by substituting for Regulation 20 the following— | ||
“Notwithstanding section 57 of the Act of 1998, a summary offence under these Regulations may be prosecuted by: | ||
(a) the Authority, or | ||
(b) an official agency.” | ||
(e) by substituting for Schedule 1 the Schedule set out in Schedule 1 to these Regulations. | ||
(f) by substituting for Schedule 2 the Schedule set out in Schedule 2 to these Regulations. | ||
Schedule 1 Vitamins and minerals which may be used in the manufacture of food supplements | ||
| ||
(*) Folic acid is the term included in Annex I of Commission Directive 2008/100/EC of 28 October 2008 amending Council Directive 90/496/EEC on nutrition labelling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions for nutrition labelling purposes and covers all forms of folates. | ||
Schedule 2 Vitamin and mineral substances which may be used in the manufacture of food supplements | ||
A. Vitamins | ||
1. VITAMIN A | ||
(a) retinol | ||
(b) retinyl acetate | ||
(c) retinyl palmitate | ||
(d) beta-carotene | ||
2. VITAMIN D | ||
(a) cholecalciferol | ||
(b) ergocalciferol | ||
3. VITAMIN E | ||
(a) D-alpha-tocopherol | ||
(b) DL-alpha-tocopherol | ||
(c) D-alpha-tocopheryl acetate | ||
(d) DL-alpha-tocopheryl acetate | ||
(e) D-alpha-tocopheryl acid succinate | ||
(f) mixed tocopherols (*) | ||
(g) tocotrienol tocopherol (**) | ||
4. VITAMIN K | ||
(a) phylloquinone (phytomenadione) | ||
(b) menaquinone (***) | ||
5. VITAMIN B1 | ||
(a) thiamin hydrochloride | ||
(b) thiamin mononitrate | ||
(c) thiamine monophosphate chloride | ||
(d) thiamine pyrophosphate chloride | ||
6. VITAMIN B2 | ||
(a) riboflavin | ||
(b) riboflavin 5'-phosphate, sodium | ||
7. NIACIN | ||
(a) nicotinic acid | ||
(b) nicotinamide | ||
(c) inositol hexanicotinate (inositol hexaniacinate) | ||
8. PANTOTHENIC ACID | ||
(a) D-pantothenate, calcium | ||
(b) D-pantothenate, sodium | ||
(c) dexpanthenol | ||
(d) pantethine | ||
9. VITAMIN B6 | ||
(a) pyridoxine hydrochloride | ||
(b) pyridoxine 5'-phosphate | ||
(c) pyridoxal 5'-phosphate | ||
10. FOLATE | ||
(a) pteroylmonoglutamic acid | ||
(b) calcium-L-methylfolate | ||
11. VITAMIN B12 | ||
(a) cyanocobalamin | ||
(b) hydroxocobalamin | ||
(c) 5'-deoxyadenosylcobalamin | ||
(d) methylcobalamin | ||
12. BIOTIN | ||
(a) D-biotin | ||
13. VITAMIN C | ||
(a) L-ascorbic acid | ||
(b) sodium-L-ascorbate | ||
(c) calcium-L-ascorbate (****) | ||
(d) potassium-L-ascorbate | ||
(e) L-ascorbyl 6-palmitate | ||
(f) magnesium L-ascorbate | ||
(g) zinc L-ascorbate | ||
B. Minerals | ||
calcium acetate | ||
calcium L-ascorbate | ||
calcium bisglycinate | ||
calcium carbonate | ||
calcium chloride | ||
calcium citrate malate | ||
calcium salts of citric acid | ||
calcium gluconate | ||
calcium glycerophosphate | ||
calcium lactate | ||
calcium pyruvate | ||
calcium salts of orthophosphoric acid | ||
calcium succinate | ||
calcium hydroxide | ||
calcium L-lysinate | ||
calcium malate | ||
calcium oxide | ||
calcium L-pidolate | ||
calcium L-threonate | ||
calcium sulphate | ||
magnesium acetate | ||
magnesium L-ascorbate | ||
magnesium bisglycinate | ||
magnesium carbonate | ||
magnesium chloride | ||
magnesium salts of citric acid | ||
magnesium gluconate | ||
magnesium glycerophosphate | ||
magnesium salts of orthophosphoric acid | ||
magnesium lactate | ||
magnesium L-lysinate | ||
magnesium hydroxide | ||
magnesium malate | ||
magnesium oxide | ||
magnesium L-pidolate | ||
magnesium potassium citrate | ||
magnesium pyruvate | ||
magnesium succinate | ||
magnesium sulphate | ||
magnesium taurate | ||
magnesium acetyl taurate | ||
ferrous carbonate | ||
ferrous citrate | ||
ferric ammonium citrate | ||
ferrous gluconate | ||
ferrous fumarate | ||
ferric sodium diphosphate | ||
ferrous lactate | ||
ferrous sulphate | ||
ferric diphosphate (ferric pyrophosphate) | ||
ferric saccharate | ||
elemental iron (carbonyl + electrolytic + hydrogen reduced) | ||
ferrous bisglycinate | ||
ferrous L-pidolate | ||
ferrous phosphate | ||
iron (II) taurate | ||
cupric carbonate | ||
cupric citrate | ||
cupric gluconate | ||
cupric sulphate | ||
copper L-aspartate | ||
copper bisglycinate | ||
copper lysine complex | ||
copper (II) oxide | ||
sodium iodide | ||
sodium iodate | ||
potassium iodide | ||
potassium iodate | ||
zinc acetate | ||
zinc L-ascorbate | ||
zinc L-aspartate | ||
zinc bisglycinate | ||
zinc chloride | ||
zinc citrate | ||
zinc gluconate | ||
zinc lactate | ||
zinc L-lysinate | ||
zinc malate | ||
zinc mono-L-methionine sulphate | ||
zinc oxide | ||
zinc carbonate | ||
zinc L-pidolate | ||
zinc picolinate | ||
zinc sulphate | ||
manganese ascorbate | ||
manganese L-aspartate | ||
manganese bisglycinate | ||
manganese carbonate | ||
manganese chloride | ||
manganese citrate | ||
manganese gluconate | ||
manganese glycerophosphate | ||
manganese pidolate | ||
manganese sulphate | ||
sodium bicarbonate | ||
sodium carbonate | ||
sodium chloride | ||
sodium citrate | ||
sodium gluconate | ||
sodium lactate | ||
sodium hydroxide | ||
sodium salts of orthophosphoric acid | ||
potassium bicarbonate | ||
potassium carbonate | ||
potassium chloride | ||
potassium citrate | ||
potassium gluconate | ||
potassium glycerophosphate | ||
potassium lactate | ||
potassium hydroxide | ||
potassium L-pidolate | ||
potassium malate | ||
potassium salts of orthophosphoric acid | ||
L-selenomethionine | ||
selenium enriched yeast (*****) | ||
selenious acid | ||
sodium selenate | ||
sodium hydrogen selenite | ||
sodium selenite | ||
chromium (III) chloride | ||
chromium (III) lactate trihydrate | ||
chromium nitrate | ||
chromium picolinate | ||
chromium (III) sulphate | ||
ammonium molybdate (molybdenum (VI)) | ||
potassium molybdate (molybdenum (VI)) | ||
sodium molybdate (molybdenum (VI)) | ||
calcium fluoride | ||
potassium fluoride | ||
sodium fluoride | ||
sodium monofluorophosphate | ||
boric acid | ||
sodium borate | ||
choline-stabilised orthosilicic acid | ||
silicon dioxide | ||
silicic acid (******) | ||
(*) alpha-tocopherol < 20 %, beta-tocopherol < 10 %, gamma-tocopherol 50-70 % and delta-tocopherol 10-30 % | ||
(**) Typical levels of individual tocopherols and tocotrienols: | ||
— 115 mg/g alpha-tocopherol (101 mg/g minimum), | ||
— 5 mg/g beta-tocopherol (< 1 mg/g minimum), | ||
— 45 mg/g gamma-tocopherol (25 mg/g minimum), | ||
— 12 mg/g delta-tocopherol (3 mg/g minimum), | ||
— 67 mg/g alpha-tocotrienol (30 mg/g minimum), | ||
— < 1 mg/g beta-tocotrienol (< 1 mg/g minimum), | ||
— 82 mg/g gamma-tocotrienol (45 mg/g minimum), | ||
— 5 mg/g delta-tocotrienol (< 1 mg/g minimum), | ||
(***) Menaquinone occurring principally as menaquinone-7 and, to a minor extent, menaquinone-6. | ||
(****) May contain up to 2 % of threonate. | ||
(*****) Selenium-enriched yeasts produced by culture in the presence of sodium selenite as selenium source and containing, in the dried form as marketed, not more than 2,5 mg Se/g. The predominant organic selenium species present in the yeast is selenomethionine (between 60 and 85 % of the total extracted selenium in the product). The content of other organic selenium compounds including selenocysteine shall not exceed 10 % of total extracted selenium. Levels of inorganic selenium normally shall not exceed 1 % of total extracted selenium. | ||
(******) In the form of gel.’ | ||
| ||
GIVEN under my Official Seal, | ||
15 July 2010. | ||
MARY HARNEY, | ||
Minister for Health and Children. | ||
EXPLANATORY NOTE | ||
(This note is not part of the Instrument and does not purport to be a legal interpretation). | ||
These Regulations give partial effect to Commission Regulation (EC) No. 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European Parliament and of the Council and Regulation (EC) No. 1925/2006 of the European Parliament and of the Council as regards the lists of vitamin and minerals and their forms that can be added to foods, including food supplements. | ||
These Regulations contain enforcement provisions to give further effect to Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of Member States relating to food supplements and amend the European Communities (Food Supplements) Regulations 2007 ( S.I. No. 506 of 2007 ) in the manner specified in these Regulations. | ||
These Regulations may be cited as the European Communities (Food Supplements) (Amendment) Regulations 2010. | ||
(*) Folic acid is the term included in Annex I of Commission Directive 2008/100/EC of 28 October 2008 amending Council Directive 90/496/EEC on nutrition labelling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions for nutrition labelling purposes and covers all forms of folates. |